Design of Flavonoid‐Based Lipid Domains as Fusion Inhibitors to Efficiently Block Coronavirus and Other Enveloped Virus Infection
Small · 2025
DOI: 10.1002/smll.202410727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Nikesh Dewangan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, 741246, India. Hauptthemen laut MEDLINE: Flavonoids, Antiviral Agents, Drug Design, Lipids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Science and Engineering Research Board, Indian Council of Medical Research.
Abstract (Originalsprache)
Developing a broad‐spectrum antiviral is imperative in light of the recent emergence of recurring viral infections. The critical role of host‐virus attachment and membrane fusion during enveloped virus entry is a suitable target for developing broad‐spectrum antivirals. A new class of flavonoid‐based fusion inhibitors are designed to alter the membrane's physical properties. These flavonoid‐based molecules (MFDA; myristoyl flavonoid di‐aspartic acid) are self‐assembled in the membrane, creating distinct nanodomains and effectively inhibiting membrane fusion by modulating the membrane's interfacial properties. The broad‐spectrum antiviral efficacy of these compounds are established in effectively blocking the entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2), Type A Influenza, Human coronavirus OC43 (HCoV‐OC43), and Vesicular stomatitis virus (VSV). A slightly more effectivity of MFDA in coronavirus infection than other enveloped viruses may be attributed to its secondary interaction with the receptor binding domain (RBD) of the SARS‐CoV‐2 spike protein. A membrane nanodomain formation strategy is highlighted with natural‐product‐based fusion inhibitors, effectively thwarting the infection of several enveloped viruses, entailing their broad‐spectrum antiviral functionality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, 741246, India.
- Department of Bioscience & Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, 721302, India.
- Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, 741246, India.
ORCID-Profile: Pradip K Tarafdar
Förderung
- Science and Engineering Research Board
- Indian Council of Medical Research
Zitieren
APA
Dewangan, N., Jana, I. D., Yadav, S., Sardar, A., Mallick, A. I., Mondal, A., & Tarafdar, P. K. (2025). Design of Flavonoid‐Based Lipid Domains as Fusion Inhibitors to Efficiently Block Coronavirus and Other Enveloped Virus Infection. Small. https://doi.org/10.1002/smll.202410727
Vancouver
Dewangan N, Jana ID, Yadav S, Sardar A, Mallick AI, Mondal A, et al. Design of Flavonoid‐Based Lipid Domains as Fusion Inhibitors to Efficiently Block Coronavirus and Other Enveloped Virus Infection. Small. 2025. doi:10.1002/smll.202410727
BibTeX
@article{Dewangan2025,
author = {Dewangan, Nikesh and Jana, Indrani Das and Yadav, Sandeep and Sardar, Avijit and Mallick, Amirul I and Mondal, Arindam and Tarafdar, Pradip K},
title = {Design of Flavonoid‐Based Lipid Domains as Fusion Inhibitors to Efficiently Block Coronavirus and Other Enveloped Virus Infection},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202410727}
}
EUVIMED